CDT Equity Inc.
CDTNasdaqCIK 1896212HealthcareFiscal year ends Dec 31
Reports and events: 131 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:58 ET | DEF 14A | Proxy statementPeriod 2026-10-27 | 0001493152-26-048693 |
| 2026-10-2716:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753926-26-002007 |
| 2026-10-2708:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048638 |
| 2026-10-1308:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-046738 |
| 2026-09-2508:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044248 |
| 2026-09-1817:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-043398 |
| 2026-09-0817:30 ET | S-1 | Registration statement | 0001493152-26-041808 |
| 2026-09-0416:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041533 |
| 2026-09-0218:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753926-26-001696 |
| 2026-09-0116:15 ET | 8-K | 8.01 Other events | 0001493152-26-041016 |
| 2026-09-0108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-040929 |
| 2026-08-2109:27 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-039588 |
| 2026-08-2109:27 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-039587 |
| 2026-08-1217:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037458 |
| 2026-08-1108:45 ET | DEF 14A | Proxy statementPeriod 2026-08-11 | 0001493152-26-036998 |
| 2026-08-0616:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-036361 |
| 2026-08-0316:15 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-035831 |
| 2026-07-3117:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-035682 |
| 2026-07-2916:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-035202 |
| 2026-07-1608:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-033455 |
| 2026-07-1516:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-033380 |
| 2026-07-0717:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-032375 |
| 2026-06-2916:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-031093 |
| 2026-06-2318:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753926-26-001042 |
| 2026-06-1617:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028909 |
| 2026-05-2816:30 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025629 |
| 2026-05-1516:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-023707 |
| 2026-05-1408:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753926-26-000869 |
| 2026-04-2716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-019133 |
| 2026-04-1517:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-016858 |
| 2026-03-3021:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001753926-26-000581 |
| 2026-03-2508:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012538 |
| 2026-03-1816:53 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-011270 |
| 2026-03-0916:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-009367 |
| 2026-03-0616:12 ET | DEF 14A | Proxy statementPeriod 2026-03-06 | 0001493152-26-009143 |
| 2026-02-2417:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-007906 |
| 2026-01-2216:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-003244 |
| 2026-01-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000143 |
| 2025-12-2216:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-028760 |
| 2025-12-1216:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-027489 |
| 2025-11-1316:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022373 |
| 2025-10-0908:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017533 |
| 2025-09-2217:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-014521 |
| 2025-08-1417:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024140 |
| 2025-08-1416:55 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-03-31 | 0001641172-25-024123 |
| 2025-08-1413:11 ET | 8-K | 4.02 Non-reliance on financial statements | 0001641172-25-023840 |
| 2025-08-0816:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022760 |
| 2025-07-3119:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-021793 |
| 2025-07-0812:04 ET | DEF 14A | Proxy statementPeriod 2025-07-08 | 0001641172-25-018242 |
| 2025-06-0916:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014322 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.